Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Classification of Myeloproliferative Neoplasms: Rationale, Historical Background and Future Perspectives with Focus on Unclassifiable Cases
Marco Pizzi, Giorgio Alberto Croci, Marco Ruggeri, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5666-5666
Open Access | Times Cited: 20

Showing 20 citing articles:

Classification of Myelodysplastic, Myeloproliferative, and Myelodysplastic/Myeloproliferative Neoplasms: The Past, Present, and Future
Daniel A. Arber, Attilio Orazi
American Journal of Hematology (2025)
Open Access
Correlation of cytogenetics and grade of bone marrow fibrosis in primary myelofibrosis
Vesna Djordjević, Maja Peruničić-Jovanović, Dijana Šefer, et al.
Srpski medicinski casopis Lekarske komore (2025) Vol. 6, Iss. 1, pp. 52-63
Open Access
The personal impact of living with a myeloproliferative neoplasm
Annemiek Eppingbroek, Lilian Lechner, E. C. Bakker, et al.
Psycho-Oncology (2024) Vol. 33, Iss. 4
Open Access | Times Cited: 2
SOHO State of the Art Updates and Next Questions | Diagnosis, Outcomes, and Management of Prefibrotic Myelofibrosis
Pankit Vachhani, Sanam Loghavi, Prithviraj Bose
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 7, pp. 413-426
Closed Access | Times Cited: 1
Extrahepatic portal hypertension in myeloproliferative diseases, features of diagnosis and therapeutic tactics
P. A. Batrov, Elena Lukina, K. I. Danishyan, et al.
Endoscopic Surgery (2024) Vol. 30, Iss. 1, pp. 67-67
Closed Access | Times Cited: 1
Национальные клинические рекомендации по диагностике и лечению Ph-негативных миелопролиферативных новообразований (истинной полицитемии, эссенциальной тромбоцитемии, первичного миелофиброза) (редакция 2024 г.)
Анаит Левоновна Меликян, Irina N. Subortseva, А. М. Ковригина, et al.
Clinical oncohematology (2024) Vol. 17, Iss. 3, pp. 291-334
Open Access | Times Cited: 1
MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients
Stefanie Jilg, Juliana Schwaab, Katja Sockel, et al.
Annals of Hematology (2024) Vol. 103, Iss. 10, pp. 4065-4077
Closed Access | Times Cited: 1
Targeting Ca2+ and Mitochondrial Homeostasis by Antipsychotic Thioridazine in Leukemia Cells
Vivian Moraes, Vivian M. Santos, Eloah Rabello Suarez, et al.
Life (2022) Vol. 12, Iss. 10, pp. 1477-1477
Open Access | Times Cited: 7
Myelodysplastic syndromes mortality in Spain: a comprehensive age-period-cohort and joinpoint analysis
R Rojas, Lucía Cayuela, Francisco Martín-Domínguez, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 4, pp. 917-923
Closed Access | Times Cited: 3
How I manage myeloproliferative neoplasm‐unclassifiable: Practical approaches for 2022 and beyond
Donal P. McLornan, Rupen Hargreaves, Juan Carlos Hernández‐Boluda, et al.
British Journal of Haematology (2022) Vol. 197, Iss. 4, pp. 407-416
Closed Access | Times Cited: 4
Clonal hematopoiesis in clinical practice: walking a tightrope
Francesco Tarantini, Cosimo Cumbo, Luisa Anelli, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 11, pp. 2536-2544
Closed Access | Times Cited: 4
Real-World Impact of Deep Targeted Sequencing on Erythrocytosis and Thrombocytosis Diagnosis: A Reference Centre Experience
Alberto Blanco Sánchez, Rodrigo Gil-Manso, Rodrigo de Nicolás, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3149-3149
Open Access
Subarachnoid haemorrhage in a newly diagnosed Chronic Myelogenous Leukemia patient: A diagnostic challenge
Zekewos Demissie, Brook Alemayehu, Nahom Zemedkun, et al.
Ethiopian Medical Journal (2024) Vol. 62, Iss. 2, pp. 121-125
Open Access
Identification of Myeloproliferative Neoplasms using Deep Learning
Soby Abraham, Bhumireddy Penchalareddy, S. Sumam David, et al.
(2024), pp. 62-66
Closed Access
Biomolecular Components of Blood and Their Role in Health and Diseases
Arunim Shah, Santosh K. Srivastava, Charu Chaturvedi
(2024), pp. 289-322
Closed Access
A Review on the Role of Molecular Genetics in the Diagnostic Workup of BCR::ABL1-Negative Myeloproliferative Neoplasms
Madhavi Maddali, Arun Kumar Arunachalam, Alpesh Kumar BipinBhai Kapadia, et al.
Indian Journal of Medical and Paediatric Oncology (2023) Vol. 44, Iss. 06, pp. 578-584
Open Access | Times Cited: 1
Toxicity of targeted anticancer treatments on the liver in myeloproliferative neoplasms
Shubhrat Purwar, Anam Fatima, Himashree Bhattacharyya, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 9, pp. 1021-1032
Open Access | Times Cited: 1
Splenomegaly: Dare to think rare
Natalia Scaramellini, Giorgio Alberto Croci, Claudio De Magistris, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 9, pp. 1259-1265
Closed Access | Times Cited: 1
Recent advances in the application of induced pluripotent stem cell technology to the study of myeloid malignancies
Dharamveer Tatwavedi, Andrea Pellagatti, Jacqueline Boultwood
Advances in Biological Regulation (2023) Vol. 91, pp. 100993-100993
Open Access
Effectiveness of Ropeginterferon Alfa-2B in High-Risk Patients with Philadelphia Chromosome Negative Myeloproliferative Neoplasms– Evaluation of Clinicohaematologic Response, and Safety Profile: Single Centre Experience
Marija Popova-Labachevska, Milche Cvetanoski, Nevenka Ridova, et al.
PRILOZI (2023) Vol. 44, Iss. 3, pp. 57-62
Open Access
Page 1

Scroll to top